Meeting
2016 Gastrointestinal Cancers Symposium
A pooled analysis of the secondary resection for colorectal cancer liver metastases: Comparison of bevacizumab (Bmab) and anti-EGFRs.
Authors
Wataru Ichikawa
Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Japan
Wataru Ichikawa , Yu Sunakawa , Hirofumi Nakayama , Toshikazu Ikusue , Toshikado Kaneta , Hiromi Imataka , Takashi Sekikawa , Yasutsuna Sasaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 610)
DOI
10.1200/jco.2016.34.4_suppl.610
Abstract #
610
Poster Bd #
F15
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Liver and/or lung metastasectomy after cetuximab or bevacizumab+FOLFIRI chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC).
First Author: Sang-A Kim
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Preoperative chemotherapy prior to primary tumor resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: A multicenter randomized controlled trial.
First Author: Qi Lin
Poster
2018 ASCO Annual Meeting
A randomized phase II study of perioperative chemotherapy plus bevacizumab versus postoperative chemotherapy plus bevacizumab inpatients with upfront resectable hepatic colorectal metastases (APPROACH).
First Author: You Jin Chun
Poster
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
First Author: Nicholas Adam Bosma